Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study
Source
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in Belgium
Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
A microfluidic in vitro three-dimensional dynamic model of the blood-brain barrier to study the transmigration of immune cells
Source
Brain Sciences - ISSN 2076-3425-12:10 (2022) p. 1-23
Transmigration across a steady-state blood-brain barrie induces activation of circulating dendritic cells partly mediated by actin cytoskeletal reorganization
Source
Membranes - ISSN 2077-0375-11:9 (2021) p.
Breaching the barrier-targeting dendritic cell migration in the treatment of multiple sclerosis
Source
Antwerpen, Universteit Antwerpen, Faculteit Geneeskunde en Gezondheidswetenschappen, 2021,263 p.